Guanosine triphosphate
Guanosine triphosphate (Guanosine-5'-triphosphate to be precise or also commonly abbreviated GTP for simplicity) is a high energy nucleotide (not to be confused with nucleoside) found in the cytoplasm or polymerised to form the guanine base.

GTP has selective roles in the formation of RNA strands[1], functioning as an energy carrier molecule for protein synthesis[2], a coenzyme, a predecessor to cGMP - a secondary messenger molecule[3] or as an effector molecule. The last two are commonly demonstrated by G-protein modulation[4]. All of these are a result of it's complex three dimensional structure and the variety of different chemical groups which it comprises of. For simplicity it can therefore be thought of as a maltitude of different functional groups that practically carry out different functions in isolation (although at times the structure will be involved e.g. when it interacts with an enzyme and another substrate) e.g only the triphosphate is involved in releasing energy for polymerisation while only the guanine base is involved in it's deamination. It is important to note that the list given at the start does not exhuast it's chemical interactions but is merely a demonstration of it's various capabilities.
In GTP the ribose sugar is central to the three dimensional arrangement of the covalently bonded guanine and triphosphate molecules. This monosaccharide provide hydroxyl groups for condensation reactions and nucleophilic attacks[5].The guanine molecule and the triphosphate form covalent bonds at C'1 and C'5 atoms respectively. The purine is bonded as a result of a condensation reaction at it's 9'N. Since guanine is a purine base, it is classified as a purine triphosphate along with adenine triphosphate (ATP)[6]. It is formed along with ATP through inosine monophosphate modification[7]. It's structural formula (right) suggests it's chemical activity and is described further in detail below. 1234
Misconception: GTP, A Baseline Building Block

The liver is the principal organ which synthesises nucleotides. It does so by first creating inosine monophosphate from ATP, glutamine, glycine, CO2, aspartate and formate[8]. IMP can then be modified to yield any purine

<span style="font-size: 13.28px;" />
nucleotide. In the case of GTP formation, IMP is first converted into XMP by IMP dehydrogenase. This allows for the action of GTP synthase which rapidly converts XMP into GMP[9]. GMP is then phosphorylated by nucleoside phosphate kinases to yield diphosphates and eventually triphosphates.
GTP is catabolised into insoluble uric acid which is present in the urine as sodium urate crystals[10]. Gout is a manifestation of the abnormal catabolism of purine triphosphates in the synovial joints. This leads to the presence of monosodium urate or calcium pyrophosphate dihydrate which causes clinical symptoms of inflammation and arthritis[11]. Severe combined immunodeficieny disease also can occur as a result of abnormal catabolism of purine triphosphates, which results in the destruction of B and T lymphocytes[12].
One Of Many RNA Base Predecesors
RNA is chemically distinct from DNA primarily as a result of the existance of a deoxyribose instead of a ribose sugar. Guanosine triphosphate is concerned with the production of the guanine base only in RNA[13]. In DNA

<span style="font-size: 13.28px;" />
deoxyguanosine triphosphates a
re used instead, as they do not possess a 2'OH group which makes them prone to nucleophilic attacks which can result in the hydrolysis of the base from the rest of the polynucleotide.
Guanosine triphosphate will result in the formation of a guanine base as a result of cleavage of two anhydride bonds, releasing two free phosphates as products. However, this reaction will (normally) only be catalysed byRNA polymerase i
f the opposite base is a cytosine with which the guanosine triphosphate can form hydrogen bonds. It should be noted that this occurs independantly from the action of RNA polymerase, which merely forms phosphodiester bonds between already aligned triphosphates. After catalysis, the molecule is part of a polynucleotide chain and is no longer known as GTP, but as the base guanine.
GTP; A Cousin of Universal ATP
The underlying mechanisms of yielding energy from anhydride bond cleavage is practically the same in all triphosphates. The high energy status of triphosphates is achieved through three distinct mechanisms. The first is due to the repulsive forces

on each of the phosphate groups. This contributes to a high instability of the bonded triphosphates and a high "desire" to achieve a lower energy status[14]. The second is due to

<span style="font-size: 13.28px;" />
resonance stabilisation. When GTP is converted into GDP the amount of
possible positions for the e
xistant electron pairs increases, lending to a greater stability[15]. This argument is also upheld with conversion into GMP. The third is due to the unfavourable entropic effect an increased amount of phosphates have on the conformation of water molecules that surround the molecule[16].
Since GTP concentration in the cytoplasm is significantly lower than that of ATP, it is used for specific functions for cell metabolic processes.
Primarily it is utilised for protein synthesis when coupled with IF2 during ribosomal initiation, Ef-Tu and
Ef-G during elongation and RF3 during termination (look left for the basic structure of the ribosomal complex) All of the GTP molecules that bind with the stated protein become hydrolysed in their distinct processes, releasing GDP and a free phosphate[17].
In addition, GTP is also utilised by tubulin dimers in the formation of microtubules. Tubulin dimers are composed of alpha and beta tubulin, each of which possess binding sites for GTP[18]. Since beta tubulin exists at the plus end of the filament it is always hydrolysed when another dimer is added to the lengthening polymer. The hydrolysis of GTP weakens the non-covalent interactions between tubulin dimers are results in a facilitated ability to dissolve the microtubules when necessary[19]. However, the alpha tubulin protein is not hydrolysed so it can be considered to be consistant throught the microtubule structure.
A Resource for Signalling

GTP can also be used as a reactant to produce cGMP which is a relatively common secondary signalling molecule. This catalysis is triggered by the release of NO which activates guanylate cyclase which consequently produces cGMP form GTP[23]. This secondary messenger can act as an effector towards protein kinases which phosphorylate and modify the action of specific proteins.
References
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ R K Murray, D A Bender, K M Botham, P J Kennelly, V W Rodwell and P A Weil. Harper's Illustrated Biochemistry. 28th Edition. Beijing, China. 2009.
- ↑ J Dow, G Lindsay and J Morrison, Biochemistry: Molecules, Cells and the Body. 1st Edition. Wokingham, England. Addison-Wesley. 1996.
- ↑ J Dow, G Lindsay and J Morrison, Biochemistry: Molecules, Cells and the Body. 1st Edition. Wokingham, England. Addison-Wesley. 1996.
- ↑ J Dow, G Lindsay and J Morrison, Biochemistry: Molecules, Cells and the Body. 1st Edition. Wokingham, England. Addison-Wesley. 1996.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ M W King. The Medical Biochemistry Page. September 2016. Cited: 11:31. 03.12.2016. Available from: http://themedicalbiochemistrypage.org/nucleotide-metabolism.php#purine
- ↑ M W King. The Medical Biochemistry Page. September 2016. Cited: 11:31. 03.12.2016. Available from: http://themedicalbiochemistrypage.org/nucleotide-metabolism.php#purine
- ↑ M W King. The Medical Biochemistry Page. September 2016. Cited: 11:31. 03.12.2016. Available from: http://themedicalbiochemistrypage.org/nucleotide-metabolism.php#purine
- ↑ M W King. The Medical Biochemistry Page. September 2016. Cited: 11:31. 03.12.2016. Available from: http://themedicalbiochemistrypage.org/nucleotide-metabolism.php#purine
- ↑ M W King. The Medical Biochemistry Page. September 2016. Cited: 11:31. 03.12.2016. Available from: http://themedicalbiochemistrypage.org/nucleotide-metabolism.php#purine
- ↑ J Dow, G Lindsay and J Morrison, Biochemistry: Molecules, Cells and the Body. 1st Edition. Wokingham, England. Addison-Wesley. 1996.
- ↑ J M Berg, J L Tymoczko, G J Gatto and R Stryer. Biochemistry. Eighth Edition. City and Country Unidentified. Freeman and Co. 2015.
- ↑ J M Berg, J L Tymoczko, G J Gatto and R Stryer. Biochemistry. Eighth Edition. City and Country Unidentified. Freeman and Co. 2015.
- ↑ J M Berg, J L Tymoczko, G J Gatto and R Stryer. Biochemistry. Eighth Edition. City and Country Unidentified. Freeman and Co. 2015.
- ↑ T E Dever and R Green. The Elongation, Termination and Recycling phases in Eukaryotes. CSHPB. July 2012. 4:7:1-16
- ↑ B Alberts et al. Molecular Biology of The Cell. 6th Edition. New York, USA. Garland Science. 2015.
- ↑ B Alberts. Molecular Biology of The Cell. 6th Edition. New York, USA. Garland Science. 2015.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.
- ↑ J Koolman and KH Roehm, Color Atlas of Biochemistry, 3rd Edition, Stuttgart, Germany. Thieme 2013.